CLINICAL TRIALS PROFILE FOR ZILRETTA
✉ Email this page to a colleague
All Clinical Trials for Zilretta
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02116972 ↗ | Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee | Completed | Flexion Therapeutics, Inc. | Phase 2 | 2014-04-01 | The purpose of this study was to assess the magnitude and duration of pain relief of a single IA injection of 2 doses (16 and 32 mg) of FX006, an extended-release formulation of TCA, relative to normal saline (placebo control). |
NCT02357459 ↗ | Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee | Completed | Flexion Therapeutics, Inc. | Phase 3 | 2015-01-01 | The purpose of this study was to assess the safety and efficacy of FX006 for the treatment of pain in patients with osteoarthritis of the knee. |
NCT02468583 ↗ | Proof of Concept Study Comparing FX006 to KenalogĀ®-40 in Patients With Post-Traumatic Osteoarthritis of the Knee | Terminated | Flexion Therapeutics, Inc. | Phase 2 | 2015-02-01 | This study was a double-blind, randomized, parallel group, proof of concept study comparing FX006 to KenalogĀ®-40 (triamcinolone acetonide injectable suspension, USP) in patients with post-traumatic osteoarthritis of the knee. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Zilretta
Condition Name
Clinical Trial Locations for Zilretta
Trials by Country
Clinical Trial Progress for Zilretta
Clinical Trial Phase
Clinical Trial Sponsors for Zilretta
Sponsor Name